MARKET

ERNA

ERNA

Ernexa
NASDAQ
6.97
-0.43
-5.81%
After Hours: 7.11 +0.14 +2.01% 19:59 06/26 EDT
OPEN
6.91
PREV CLOSE
7.40
HIGH
7.23
LOW
5.16
VOLUME
81.26K
TURNOVER
--
52 WEEK HIGH
71.50
52 WEEK LOW
3.183
MARKET CAP
8.13M
P/E (TTM)
-0.2286
1D
5D
1M
3M
1Y
5Y
1D
Eterna Therapeutics announces finance leadership transition and search
TipRanks · 7h ago
Ernexa Therapeutics SVP of Finance Sandra Gurrola resigns effective July 3
PUBT · 8h ago
Top Biotech Gainers: TECH Bought Out, MSLE On Watch, KYMR Hits New High, What's The Buzz At SLS?
NASDAQ · 1d ago
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
Barchart · 1d ago
Weekly Report: what happened at ERNA last week (0615-0619)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 06/18 12:06
Ernexa expects FDA review of ERNA-101 IND in Q4 2026
PUBT · 06/17 13:27
ERNEXA THERAPEUTICS - PLANS IND SUBMISSION FOR ERNA-101 IN Q3 2026 AND PHASE 1 STUDY IN Q4 2026
Reuters · 06/17 12:48
More
About ERNA
Ernexa Therapeutics Inc., formerly Eterna Therapeutics Inc., is a preclinical-stage company. The Company is focused on using cutting-edge gene-editing tools to deliver safe off-the-shelf cell therapies for the treatment of advanced solid tumors. Its Pipeline includes ERNA-101, and ERNA-102. Its core technology utilizes engineer allogenic-induced pluripotent stem cells (iPSCs) to express genes of interest and to efficiently differentiate these cells into mesenchymal stem cells (iMSCs). The Company seeks to capitalize on the intrinsic tumor-homing ability of MSCs to slip through the tumor’s defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment (TME), thus unleashing potent anti-cancer immune responses. The Company is focused on developing iPSC-derived iMSC that express critical factors, such as pro-inflammatory cytokines.

Webull offers Ernexa Therapeutics Inc stock information, including NASDAQ: ERNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ERNA stock methods without spending real money on the virtual paper trading platform.